Q98529607

Summary

Q98529607 is a committee directives^[1].

Key Facts

• Q98529607 is in the country of Sweden^[2].
• Q98529607's instance of is recorded as committee directives^[3].
• Q98529607's part of the series is recorded as committee directives from 2014^[4].
• Q98529607's language of work or name is recorded as Swedish^[5].
• Q98529607's publication date is recorded as +2014-08-28T00:00:00Z^[6].
• Q98529607's main subject is recorded as medication^[7].
• Q98529607's work available at URL is recorded as http://data.riksdagen.se/dokument/H2B1124.html^[8].
• Q98529607's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H2B1124^[9].
• Q98529607's applies to jurisdiction is recorded as Sweden^[10].
• Q98529607's legal citation of this text is recorded as dir. 2014:124^[11].
• Q98529607's title is recorded as Tilläggsdirektiv till Läkemedels- och apoteksutredningen (S 2011:07)^[12].
• Q98529607's cites work is recorded as Q98459371^[13].
• Q98529607's cites work is recorded as Q98459413^[14].
• Q98529607's cites work is recorded as Q98459500^[15].
• Q98529607's cites work is recorded as Q98530073^[16].
• Q98529607's cites work is recorded as Q98530044^[17].
• Q98529607's cites work is recorded as Q98529834^[18].
• Q98529607's cites work is recorded as Q98529711^[19].
• Q98529607's maintained by WikiProject is recorded as Project Riksdagen's documents^[20].
• Q98529607's copyright status is recorded as public domain^[21].
• Q98529607's Swedish Riksdag document ID is recorded as H2B1124^[22].